Latest Strategic Pivot News

Central Petroleum has agreed to sell its Northern Territory sub-salt exploration permits to Georgina Energy, gaining a 25% equity stake in the helium-focused explorer. The deal refocuses Central on conventional oil and gas while offering shareholders exposure to emerging helium and hydrogen prospects.

ARN Media reports a challenging second half of FY 2025 with a 10% revenue decline and expects EBITDA to fall 25%-27%, while advancing a $40 million cost reduction program and repositioning as an entertainment business.

Scentre Group reports rising customer visits and strong sales growth across its Westfield portfolio, while confirming its 2025 earnings and distribution targets.

Locate Technologies Limited has officially launched its IPO on the New Zealand Exchange, aiming to raise NZ$1 million as part of its transition to a new parent company, Locate NZ. This move aligns with the company’s broader strategy, including its Bitcoin Treasury approach and long-term growth ambitions.

OFX Group Limited’s half-year results reveal a sharp 78% drop in statutory net profit to $2.4 million, driven by lower fee and trading income and rising expenses. The company is advancing its New Client Platform rollout and has initiated a new share buy-back program to support growth and capital management.

Invex Therapeutics Ltd has had its trading suspension lifted following an announcement of new board and officer appointments, signaling a fresh chapter for the biotech company.

Critica Limited has demonstrated a 63% recovery of gallium oxide as a valuable by-product from its vast Jupiter rare earth deposit in Western Australia, integrating seamlessly into its existing beneficiation flowsheet. This milestone enhances the project’s strategic value amid global supply chain tensions.

New Frontier Minerals has secured regulatory approval to launch its first reverse circulation drilling campaign at the Harts Range Heavy Rare Earth and Niobium Project, while also preparing for a US OTCQB listing to broaden investor reach.

Fletcher Building has completed the sale of its 13.4% stake in the Pūhoi to Warkworth toll road, marking its exit from public-private partnership investments and a renewed focus on core operations.

Epsilon Healthcare has commenced operations of its new pharmacy division and extended a key loan facility, signaling a strategic pivot towards integrated healthcare and financial stability after recent restructuring.

Nine Entertainment reports continued digital subscription growth and cost efficiencies that help offset a softer advertising market in Q1 FY26, setting the stage for EBITDA gains.

Briscoe Group reports a slight sales decline in Q3 2025 but stabilizes gross profit margins and advances key strategic projects, positioning itself cautiously for the critical fourth quarter.